State drug controllers must submit action-taken reports by 16 November as the regulator moves to ensure margin caps—which cut some therapy prices by over 90%—reach patients. The National Pharmaceutical Pricing Authority mandates nationwide monitoring to ensure compliance with reduced prices on 137 non-scheduled anti-cancer drugs. NPPA's revised prices for 137 anti-cancer drugs take effect on November 9, 2026. The government estimates annual consumer savings of ₹3,502.31 crore.